Advanced searches left 3/3

Heart Failure - PubAg

Summarized by Plex Scholar
Last Updated: 16 October 2021

* If you want to update the article please login/register

Systematic analysis of molecular mechanisms of heart failure through the pathway and network-based approach

The molecular networks and paths involved in heart failure are still greatly unknown. Genetics set variation evaluation and receiver operating characteristic contour evaluation were done to review the relationship of the hub genetics with HF. A total of 5968 HF-related genetics were acquired to create the co-expression networks, and 18 relatively independent and carefully linked modules were identified. The genes in the module with the greatest favorable relationship to HF was mainly enhanced in heart renovation and response to stress. Additionally, the GSVA ratings of the five center genetics for HF had a relatively high locations under the curve. The results of this study revealed specific molecular networks and their potential regulatory mechanisms involved in HF. These may give new insight into understanding the mechanisms underlying HF and help to recognize more reliable restorative targets for HF.

Source link: https://pubag.nal.usda.gov/catalog/7193268


Association of diet with clinical outcomes in dogs with dilated cardiomyopathy and congestive heart failure

Some dogs with assumed diet-associated DCM have shown improved myocardial function and clinical outcomes complying with a modification in diet regimen and basic medical therapy. Prior GF diet regimen influences reverse heart renovation and scientific results in dogs with DCM and congestive heart failure. A retrospective research was performed with 67 dogs with DCM and CHF for which diet history was known. pGF dogs had a considerably even worse end result the longer a GF diet regimen was fed before diagnosis or if they were detected at a more youthful age. pGF pets revealed considerably better enhancement in stabilized left ventricular inner diastolic size and E-point septal splitting up dimensions and considerable declines in their furosemide and pimobendan dosages with time contrasted to GI dogs. pGF pet dogs that survived a minimum of one week after diagnosis of DCM, treatment of CHF, and diet plan modification had better clinical end results and showed reverse ventricular remodeling contrasted to GI dogs.

Source link: https://pubag.nal.usda.gov/catalog/7284947


Correction of serum chloride concentration in dogs with congestive heart failure

BACKGROUND: Hypochloremia related to congestive heart failure in dogs is most likely multifactorial. THEORY: We hypothesized that remedied [Cl ⁻] would not vary from measured [Cl ⁻] in pets with regulated CHF as a result of loop diuretics, and pets with refractory CHF would have higher c [Cl ⁻] than m [Cl ⁻], suggesting relative water unwanted. PETS: Seventy‐one client‐owned pets with gotten cardiovascular disease, without CHF, 76 with Stage C CHF and 24 with Stage D CHF. OUTCOMES: Corrected [Cl ⁻] and m [Cl ⁻] were reduced in Stage D vs Stage C and NO‐CHF all P 2 mmol/L. VERDICTS AND CLINICAL IMPORTANCE: Serum [Cl ⁻] enhanced after mathematical modification in Stage D CHF dogs but not in Stage C and NO‐CHF pets. C [ Cl ⁻] was more than m [Cl ⁻] in Stage D pet dogs helpful of relative water excess, hypochloremia lingered, regular with simultaneous loophole diuretic impacts on electrolytes.

Source link: https://pubag.nal.usda.gov/catalog/7261180


The effect of Guanxin Shutong capsule on alleviating the myocardial fibrosis in heart failure rats

This study intended to investigate the effects of GXST capsule on ameliorating myocardial fibrosis conditions in pressure overload-induced heart failure rats. Rats were randomly split into 6 teams: Normal group, Model group, GXST-treated group at a dose of 0. 5 g/kg, 1 g/kg, 2 g/kg, specifically, and digoxin positive control team at a dose of 1 mg/kg. GXST turned around ventricular improvement could be with the TGF-β/ Smad3 pathway. GXST capsule demonstrated a solid anti-fibrosis impact in heart failure rats by hindering the TGF-β/ Smad3 signaling path.

Source link: https://pubag.nal.usda.gov/catalog/7364201


Impact of Inadequate Calorie Intake on Mortality and Hospitalization in Stable Patients with Chronic Heart Failure

Lack of nutrition is highly prevalent in patients with heart failure, but the specific impact of nutritional energy shortage on HF patients' medical end results is not recognized. We explored the associations between poor calorie intake and adverse clinical events in 145 steady outpatients with chronic HF that had a background of hospitalization due to worsening HF. A Kaplan-- Meier evaluation disclosed that the patients with inadequate calorie consumption had substantially worse scientific outcomes consisting of all-cause death and HF-related hospitalization during the 1-year follow-up duration versus those with sufficient calorie intake. A multivariate logistic regression analysis showed that poor calorie consumption was an independent forecaster of unfavorable medical occasions after modification for numerous variables that may affect patients' calorie intake. Amongst patients with persistent HF, inadequate calorie consumption was related to an enhanced danger of all-cause mortality and rehospitalization because of getting worse HF.

Source link: https://pubag.nal.usda.gov/catalog/7321653


Association of physical activity and risk of atrial fibrillation in heart failure with preserved ejection fraction

HFpEF patients are often concomitant with AF, however whether PA can change the risk of AF in HFpEF patients stays undiscovered. We done an article hoc evaluation of the TOPCAT trial. When HFpEF patients were divided into 3 tertile groups according to levels, patients in the third tertile and the 2nd tertile had dramatically reduced risks of AF occurrence when compared to those in the first tertile. Our present outcomes suggest that a higher PA degree connects with a lower risk of AF in HFpEF patients. URL: https://clinicaltrials. gov.

Source link: https://pubag.nal.usda.gov/catalog/7088793


Sarcopenia and Heart Failure

Sarcopenia might be considered one of the most vital root causes of reduced physical efficiency and decreased cardiorespiratory health and fitness in older patients with HF. Muscle mass losing in HF has various pathogenetic functions in cachectic and sarcopenic problems. In the opposite way, sarcopenia might favor HF advancement by different mechanisms, consisting of pathological ergoreflex. Paradoxically, sarcopenia is not connected with a sarcopenic cardiac muscle, yet the cardiac muscle shows a hypertrophy which seems to be "not-functional. " First-line agents for the treatment of HF, physical activity and nutritional interventions, may use a restorative advantage in sarcopenic patients irrespective of HF.

Source link: https://pubag.nal.usda.gov/catalog/7034045


Visual detection of heart failure associated MiRNA with DSN enzyme-based recycling amplification strategy

MicroRNA 21 is reported to be very closely connected with the growth of heart failure, cardiac fibrosis and hypertrophy, which might be an encouraging biomarker for the early-diagnosis of heart failure. We think that the proposed DSN enzyme based colorimetric assay can be applied to heart failure associated diagnostics.

Source link: https://pubag.nal.usda.gov/catalog/7381999


Association between fine particulate matter and heart failure hospitalizations: a time-series analysis in Yancheng, China

BACKGROUND: Heart failure is an international public wellness trouble of enhancing relevance. The association between acute exposure to air contamination and HF has been well established in established nations, however little evidence is readily available in creating nations where air contamination levels are much greater. OBJECTIVES: To explore the associations between PM ₂. ₅ and HF hospitalizations in Yancheng, China. APPROACHES: In this time-series research, everyday HF hospital stays admitted in three major healthcare facilities in Yancheng from May 1, 2015 to Apr 30, 2020 were accumulated. We used a generalized additive version with quasi-Poisson regression to explore the organization between PM ₂. ₅ and HF hospitalizations. The PM ₂. ₅-HF organizations declared in females, patients aged ≥ 65 years, and in winter. CONCLUSION: This research study gave proof on the organization of PM ₂. ₅ with acute exacerbation of persistent heart failure, which may profit future prevention strategy and policymaking.

Source link: https://pubag.nal.usda.gov/catalog/7394435


An ultrasensitive heart-failure BNP biosensor using B/N co-doped graphene oxide gel FET

Heart failure is the leading reason of death worldwide. B-type natriuretic peptide is a recognized biomarker for HF and can be utilized for very early discovery. Field impact transistor biosensors have the ability to sense BNP in much shorter times than conventional professional studies. In this work, a B/N co-doped graphene oxide gel was utilized as the channel material in an FET biosensor targeting BNP. This biosensor works as a proof-of-concept of the capacity of BN-GO gel FETs to be utilized for ultrasensitive biosensors.

Source link: https://pubag.nal.usda.gov/catalog/7301263

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions